4
Changes in Ownership
Inhibitor Therapeutics, Inc. Filed Acc 0001144204-18-037560
Options or other derivatives
- 10% owner bought 5,797,103 shares
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Mayne Pharma Ventures Pty Ltd 10% owner | 2018-07-05 | Purchase · Series B Convertible Preferred Stock | +2,318,841 | 5,797,102 | D | ||
| Mayne Pharma Ventures Pty Ltd 10% owner | 2018-07-05 | Purchase · Series A Warrants to Purchase Common Stock | +1,739,131 | 1,739,131 | D | ||
| Mayne Pharma Ventures Pty Ltd 10% owner | 2018-07-05 | Purchase · Series B Warrants to Purchase Common Stock | +1,739,131 | 1,739,131 | D | ||
Loading xslF345X03/tv498045_4.xml…